Search Market Research Report
Seborrheic Dermatitis Market Size, Share Global Analysis Report, 2022 – 2030
Seborrheic Dermatitis Market Size, Share, Growth Analysis Report By Route Of Administration (Parenteral, Topical, Oral, and Others), By Treatment (Antifungal, Anti-Inflammatory, Sulfur Products, and Others), By End-Users (Speciality Clinics, Hospitals, Homecare, and Others), By Dosage Form (Shampoos, Creams, Gels, Ointments, and Others), and By Region - Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2022 – 2030
Industry Insights
[243+ Pages Report] According to the report published by Facts and Factors, the global seborrheic dermatitis market size was worth around USD 2.2 billion in 2021 and is predicted to grow to around USD 5 billion by 2030 with a compound annual growth rate (CAGR) of roughly 11.1% between 2022 and 2030. The report analyzes the global seborrheic dermatitis market drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the seborrheic dermatitis market.
Market Overview
Seborrheic dermatitis is a non-serious medical condition that does not cause significant harm to the infected person. It is an extremely common and non-contagious disease that can be managed with minimum care. Seborrheic dermatitis causes greasy scales and leads to itchy red patches. It appears as flaky, itchy, and dry skin on the scalp along with other body parts. Seborrheic is the reference for sebaceous glands and derm stands for the skin. In common terms, it is called dandruff if it occurs on the scalp of an adult. The same condition is called cradle cap if it occurs in a baby.
Dandruff is not limited only to the scalp but can occur on other body parts as well like the upper chest, upper back, creases at the base of the nose, forehead, face, navel area, eyebrows, behind the ears, under the breast and in bends or creases of legs, arms, and groin. The symptoms of the disease include the occurrence of itchy white flakes on the skin on the scalp. If the flakes are itched, they can become loose, fall on the neck area, and mix with hair. The condition also leads to red scales on the skin.
Key Insights
- As per the analysis shared by our research analyst, the global seborrheic dermatitis market is estimated to grow annually at a CAGR of around 11.1% over the forecast period (2022-2030)
- In terms of revenue, the global seborrheic dermatitis market size was valued at around USD 2.2 billion in 2021 and is projected to reach USD 5 billion, by 2030.
- The market is projected to grow at a significant rate due to the high number of patients suffering from the condition
- Based on route of administration segmentation, topical was predicted to show maximum market share in the year 2021
- Based on dosage form segmentation, creams were the leading form in 2021
- On the basis of region, North America was the leading revenue generator in 2021
Growth Drivers
- High number of patients suffering from the condition to propel market growth
The global seborrheic dermatitis market is projected to grow owing to the high number of patients suffering from the condition on a regular basis across the globe. The medical concern is extremely common in adults. As per estimates, more than 11% of the world’s population is infected by seborrheic dermatitis. It is mostly observed in infants that are below 3 months old or in adults between 30 to 60 years of age. Men are at higher risk than women and the rate of infection is higher in Caucasians as compared to African Americans. People who are born with naturally oily skin are more likely to contract the disease or if there is a history of psoriasis then the future generation becomes more vulnerable. Patients who have several other medical conditions are also more prone to seborrheic dermatitis.
Restraints
- Lack of a completely effective cure to restrict market expansion
Even though the condition is extremely common and has long prevailed in the medical community, there is a lack of concrete treatment plan that has proven to be one hundred effective in treating the condition. Most of the plans can help manage the condition but not completely cure it. Most of the cure methods have to be customized as per the requirement and involve trial and error methods. The chances of the condition recurring are very high once the medication is switched or stopped.
Opportunities
- Increasing birth rate to provide expansion opportunities
Since seborrheic dermatitis is mostly seen in infants, the rapid rate at which the population is growing could lead to higher growth opportunities. The world population crossed the 8 billion mark on 15th November 2022. As per projections, the total population would cross the 10 billion mark by 2100.
As of 2020, the birth rate as per data from across the world is 2.39 births per woman. The other segment of the population that is more prone to the disease includes adults. As per the World Health Organization, the geriatric population was estimated to be around 253 million in 2010.
Challenges
- Impact on quality of life to become the major challenge for market players
One of the major challenges for people suffering from seborrheic dermatitis is the reduced quality of life in patients. Since the condition starts appearing on the outer ski, it can greatly diminish the confidence level of the people suffering from it. This is also caused due to the negative advertisements and sentiments associated with the condition. Studies have concluded that dandruff in adults can be associated with embarrassment and self-consciousness. It is known to be the cause of more psychological problems than medical issues.
Segmentation Analysis
The global seborrheic dermatitis market is segmented based on route of administration, treatment, end-users, dosage form, and region
Based on the route of administration, the global market is segmented as parenteral, topical, oral, and others. In 2021, the global market registered the highest growth in the topical segment since most of the medicines available in the market for the treatment of the condition are supposed to be applied externally. These medicines are available in various forms that have to be administered topically at regular intervals as recommended by the medical professional. The increasing number of topical product launches showing effective results could lead to further segmental growth. Topical ketoconazole is a popular choice. The medicine takes around 4 weeks to manage the medical problem.
Based on dosage form, the global market divisions are shampoos, creams, gels, ointments, and others. In 2021, the creams segment led the global market with the highest CAGR followed by ointments and shampoos. The latter is one of the most common methods of managing dandruff as there are specially curated hair-washing products including conditioners that claim to get rid of the condition with regular use.
However, they do not eradicate the diseases completely and the chances of the condition coming back remain high. These shampoos are recommended to be used 2 times a week for expected results.
Recent Developments:
- In December 2022, MyHealthTeam, creator of the fastest-selling social networks dedicated to helping people with chronic medical conditions, launched MySebDermTeam, an online community meant for people with seborrheic dermatitis to find other patients for mental support
- In February 2022, Arcutis announced the enrollment of the last subject for the STRATUM phase 3 trials. The study is conducted for understanding the impact of roflumilast on patients with seborrheic dermatitis
Report Scope
Report Attribute |
Details |
Market Size in 2021 |
USD 2.2 Billion |
Projected Market Size in 2030 |
USD 5 Billion |
CAGR Growth Rate |
11.1% CAGR |
Base Year |
2021 |
Forecast Years |
2022-2030 |
Key Market Players |
Pfizer Inc., F. Hoffmann-La Roche Ltd., Eli Lilly and Company, Bayer AG, Abbott, Teva Pharmaceutical Industries Ltd, and others. |
Key Segment |
By Route Of Administration, Treatment, End-Users, Dosage Form, and Region |
Major Regions Covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East &, Africa |
Purchase Options |
Request customized purchase options to meet your research needs. Explore purchase options |
Regional Analysis
- North America to lead with the highest market share
The global seborrheic dermatitis market is projected to register the highest growth in North America mainly driven by the growing number of pharmaceutical companies in the US working consistently toward the development of new and improved medical treatments against the condition. As per estimates, one in every 5 Canadian citizens is known to suffer from dandruff which can be treated with over-the-counter shampoo. Over 50% of the North American population is estimated to suffer from the condition which means that the demand for the product is also high.
The regional market could further be driven by the already developed healthcare infrastructure of the countries. Around 38% of the American population has access to health insurance coverage in 2021 which was an increase of 1.21% from 2020. The growing initiatives undertaken by the medical community of the region to normalize the condition and help create support groups for people infected with the disease have encouraged a larger group of people to seek treatment.
Competitive Analysis
- Pfizer Inc.
- F. Hoffmann-La Roche Ltd.
- Eli Lilly and Company
- Bayer AG
- Abbott
- Teva Pharmaceutical Industries Ltd
The global seborrheic dermatitis market is segmented as follows:
By Route Of Administration Segment Analysis
- Parenteral
- Topical
- Oral
- Others
By Treatment Segment Analysis
- Antifungal
- Anti-Inflammatory
- Sulfur Products
- Others
By End-Users Segment Analysis
- Speciality Clinics
- Hospitals
- Homecare
- Others
By Dosage Form Segment Analysis
- Shampoos
- Creams
- Gels
- Ointments
- Others
By Regional Segment Analysis
- North America
- The U.S.
- Canada
- Mexico
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest of the Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Content
Industry Major Market Players
- Pfizer Inc.
- F. Hoffmann-La Roche Ltd.
- Eli Lilly and Company
- Bayer AG
- Abbott
- Teva Pharmaceutical Industries Ltd
Copyright © 2023 - 2024, All Rights Reserved, Facts and Factors